Related Experiment Video

Updated: Mar 30, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K

[Eukaryotic elongation factor 2 kinase and cancer]

Gen-zhu Wang, Xin Qi, Jing Li

    Yao Xue Xue Bao = Acta Pharmaceutica Sinica
    |November 11, 2015
    PubMed

    Insights

    Eukaryotic elongation factor 2 kinase (eEF2K), a Ca2+/calmodulin-dependent kinase, negatively regulates protein synthesis. Its high expression in malignancies suggests eEF2K is a promising cancer therapy target.

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Oncology

    Background:

    • Eukaryotic elongation factor 2 kinase (eEF2K) is a calcium/calmodulin-dependent kinase.
    • eEF2K phosphorylates eEF2, inhibiting ribosome binding and protein synthesis.
    • Elevated eEF2K expression is observed in various cancers, implicating it in tumor progression.

    Purpose of the Study:

    • To summarize the relationship between eEF2K and cancer.
    • To review the latest advancements in eEF2K inhibitors for cancer therapy.

    Main Methods:

    • Literature review of studies on eEF2K function and expression in malignancies.
    • Analysis of recent research on the development and efficacy of eEF2K inhibitors.

    Main Results:

    • eEF2K plays a significant role in the development and progression of tumors.
    • Several eEF2K inhibitors are under investigation, showing potential as anti-cancer agents.

    Conclusions:

    • eEF2K is a potential therapeutic target for cancer treatment.
    • Further research into eEF2K inhibitors could lead to novel cancer therapies.

    More Related Videos

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    909
    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

    Published on: July 20, 2014

    14.5K

    Related Concept Videos

    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.1K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    1.7K
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    8.4K
    Transcription Elongation Factors02:35

    Transcription Elongation Factors

    Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
    The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
    14.4K
    Electron Transport Chain: Complex I and II01:46

    Electron Transport Chain: Complex I and II

    The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
    ROS generation is regulated and maintained at moderate levels necessary...
    19.6K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    10.1K